ADVERTISEMENT

Stay up to date every week with the european biotechnology newsletter.

✕
This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
EBcom NL
This field is hidden when viewing the form
Consent

Stay up to date every week with the european biotechnology newsletter.

Log in here to read the desired article.

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
EBcom NL
This field is hidden when viewing the form
Consent
go to the article

go back to the homepage

  • BIOCOM CARD
  • Newsletter
  • Advertising
European Biotechnology Magazine
biocom_logo
  • Latest news
  • Background
  • Opinion
  • The Mag
    • Issues
    • Special
    • Corporate publications
    • Subscribe
  • Euro Biotech Guide
  • Market Place
    • Products
    • Sponsored Publications
    • Advertise
  • Associations
  • Service
    • Newsletter
    • Contact Us
    • Editorial Team
  • Events
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

ADVERTISEMENT

SPECIALS

Special Winter 2023

Euro BioFairs Compass

Guide to Life Sciences Events in the first half year of 2024 more ➔

Special Autumn 2023

CROs & CDMOs

Since 2006, the share of biomanufacturers producing everything in-house have declined from 57.6% to 34.9% in 2022. According to biopharmaceutical companies, the percentage is to decrease to 20% by 2026, … more ➔

ADVERTISEMENT

Special Summer 2023

Euro BioFairs Compass

2nd half year 2023 more ➔

Page 2 of 212

LATEST NEWS

Image credits: Abderrahmane Habibi on Pexels.

London-based Ellipses licenses another oncologic as...

Photo credits: Pixabay

IO Biotech weighs strategic options months after FD...

Photo credits: Francesco Gallarotti

Oxford-based cancer vaccine company Infinitopes clo...

ADVERTISEMENT

MAGAZINE

1 / 4
EB425_Cover

Europe is losing much of its expertise in deep tech and life sciences to the US. To prevent another generation of innovation from being lost, Europe must close the funding gaps. more ➔

2 / 4
EB325_cover

Investors are showing enormous interest in the topic of longevity, as well as in combating chronic diseases. This is because these diseases have a negative impact on life expectancy. The USA and China … more ➔

3 / 4
01_EB225_Titel.indd

This issue focuses on the art of upscaling industrial biotechnology in Europe, the impact of the Trump factor on the life sciences and the European Commission's new billion-euro fund for emerging … more ➔

4 / 4
EB125_Cover

This issue offers insights into Europe's fight for green solutions for a bioeconomy, antimicrobial resistance and how Europe is preparing for the next pandemic. more ➔

SPONSORED PUBLICATION

SFDA Riyadh, Saudi Arabia
Regulatory

SFDA vs EMA: What Biotech Leaders need to Know

As the regulatory strategy becomes a boardroom-level concern for biotech executives pursuing global expansion, knowing how the Saudi Food and Drug Authority (SFDA) and the European Medicines Agency … more ➔

newsletter_link
Knowbio GmbH
  • Link to LinkedIn
  • Link to Instagram
  • Contact
  • Imprint
  • Privacy policy
Scroll to top Scroll to top Scroll to top